mash semaglutide approved for treatment: A new era in hepatology | Asma Zinati, BCPS, BCID posted on the topic How Semaglutide Treats MASH: The

It replicates the action of glucagon-like peptide-1, a hormone thats released after meals to signal satiety, slow gastric emptying, and support a healthy blood sugar response

Identifying Candidates for Semaglutide Treatment The semaglutide weight loss program is ideal for individuals with a BMI of 30 or above, or those with a BMI of 27 or higher who have weight-related health conditions such as hypertension, type 2 diabetes, or elevated cholesterol

Earlier evidence for retatrutide comes from a Phase 2 trial in NEJM in 2023, which reported 24.2% weight loss at 12 mg over 48 weeks

Some Medicaid plans provide coverage, but restrictions apply

Reference source not found